Endocrine Testing Market Trends

Endocrine Testing Market Trends

The increasing prevalence of chronic conditions such as thyroid, diabetes, obesity, etc. is anticipated to spur the market expansion significantly. As per the United Nations Food and Agriculture Organization (FAO), in 2020, chronic diseases accounted for around 60% of the global 56.5 million reported fatalities and nearly 46% of the world’s disease burden.
 

Additionally, obesity is recognized as one of the risk factors for both the occurrence and evaluation of other co-morbid conditions. Unhealthy body weight coupled with lack of exercise and physical movement in obese people is a cornerstone in growing concerns regarding osteoarthritis. According to the Centers for Disease Control and Prevention (CDC), the U.S. obesity prevalence accounted for 41.9% in 2021. These statistics indicate conducive scenario for the market growth as the incidence & prevalence of these chronic conditions drives the adoption of endocrine testing.
 

Also, the growing prevalence of endocrine conditions are projected to foster the industry expansion. Endocrine and metabolic diseases are among the most common contemporary human afflictions, particularly in the U.S. and other countries with generous nutrition & screening programs for high-risk individuals. According to the National Centers for Biotechnology Information (NCBI) study, in 2022, the prevalence of endocrine disorders in adults in the U.S. is estimated to be around 5%.